Please use this identifier to cite or link to this item:
|Title:||Substantial variation in post-engraftment infection prophylaxis and revaccination practice in autologous stem cell transplant patients|
|Authors:||Lim, HY;Grigg, A|
|Citation:||Internal Medicine Journal 2016, vol. 46(3) p. 347-351|
|Abstract:||There is a paucity of evidence supporting the necessity or duration of Pneumocystis jirovecii and antiviral prophylaxis as well as revaccination following autologous stem cell transplant (ASCT). A survey aimed at evaluating these policies was distributed to 34 ASCT centres across Australasia. The 26 survey respondents demonstrated significant heterogeneity in their infection prophylaxis and revaccination strategy post-transplant despite the availability of consensual guidelines|
Hematopoietic Stem Cell Transplantation
|Type of Clinical Study or Trial:||Survey|
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.